Please login to the form below

Not currently logged in
Email:
Password:

tobramycin

This page shows the latest tobramycin news and features for those working in and with pharma, biotech and healthcare.

CURx buys rights to Gilead’s lung infection drug

CURx buys rights to Gilead’s lung infection drug

Agrees deal for fosfomycin/tobramycin combination. CURx Pharmaceuticals has acquired the rights to Gilead Sciences' investigational drug for a lung infection associated with cystic fibrosis. ... Dinu Sen, CEO and founder of CURx, said that

Latest news

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics